1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsIntegrating Generative AI with Biomechanics Modeling to Advance Ventricular Disease Diagnosis and Personalized Treatment is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This grant funds projects that combine generative AI with biomechanics modeling to improve diagnosis and treatment of ventricular diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ventricular-related diseases, including hypertrophic cardiomyopathy, heart failure, and dilated cardiomyopathy, significantly contribute to the global burden of cardiovascular disease (CVD), which claims around 17. 9 million lives annually. This underscores the urgent need for enhanced prevention, diagnosis, and personalized treatment strategies.
Personalized computer-based heart modeling offers a powerful, non-invasive approach to understanding cardiac function by revealing complex structure-function relationships, are widely used in cardiac research, disease analysis, device design, and treatment planning.
Accurately predicting heart behavior is challenging due to the difficulty in measuring cardiac tissue material properties and determining the stress-free configuration from stressed myocardium in medical images.
Current methods, such as finite element analysis (FEA) for predicting biomechanical outputs and inverse FEA for identifying material properties, are robust but often slow, limiting their clinical application and the advancement of personalized cardiovascular care.
This proposal aims to develop and validate an end-to-end generative AI framework that efficiently and accurately predicts the biomechanical outputs (e.g., motion and stress) of the passively deforming bi-ventricular myocardium while identifying material properties and determining the stress-free configuration using patients' 3D imaging data and clinical measurements.
We hypothesize that generative AI models trained on this data can serve as accelerated emulators for both forward and inverse FEA tasks, enhancing personalized diagnosis and treatment of ventricular diseases.
This 3-year project focuses on passive mechanics related to the late-diastolic stage, using 3D heart imaging and clinical data from normal patients to train the generative AI framework before extending it to incorporate various diseases. Aim 1 will develop a generative AI-based FEA emulator to efficiently predict passive bi-ventricular biomechanical outputs, enabling faster patient-specific heart function analysis.
Aim 2 will create an end-to-end generative AI framework to determine stress-free configurations and optimal material parameters from 3D imaging and clinical measurements, incorporating uncertainty quantification for robust parameter estimation.
Aim 3 will establish a fine-tuning mechanism to adapt generative AI models for accurately predicting biomechanical outputs in diseased hearts, integrating patient- specific disease characteristics. Besides, this project will enhance interdisciplinary student involvement in medical research through hands-on learning and collaboration with top medical schools, fostering interest in health-related careers.
This project develops a framework for personalized heart modeling that enhances clinical decision-making and has the potential to save lives. It innovatively integrates generative AI with biomechanical modeling, using a single neural network to address both forward and inverse FEA problems for rapid predictions that outperform traditional methods.
Our close collaboration among experts in cardiovascular modeling, medical imaging, and clinical care ensures project success.
Project Number: 1R15HL181637-01 | Fiscal Year: 2025 | NIH Institute/Center: National Heart Lung and Blood Institute (NHLBI) | Principal Investigator: Lei Shi | Institution: KENNESAW STATE UNIVERSITY, KENNESAW, GA | Award Amount: $522,695 | Activity Code: R15 | Study Section: Special Emphasis Panel[ZRG1 BBBT-M (84)] View on NIH RePORTER: https://reporter. nih. gov/project-details/11221667
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments. Confirm the full requirements in the official notice before applying.
The current listing shows up to $710,653 per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Integrating Generative AI with Biomechanics Modeling to Advance Ventricular Disease Diagnosis and Personalized Treatment is funded by National Heart, Lung, and Blood Institute (NHLBI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articleThe $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read articleDARPA MTO opened six FY26 SBIR topics on May 27 with a June 24 deadline — nanopore proteomics, compact RF filters, 800°C ICs, passive thermal spreaders, radiation-hardened codesign, and low-resource computing. The topics read like a wishlist for the next decade of contested-environment microelectronics. Here is what each one is actually asking for, and how small businesses should triage the four-week window.
Read article